Effect of Mastoid Condition on Endoscopic Cholesteatoma Management
The Impact of Mastoid Condition and Ossicular Reconstruction on the Outcome of the Transcanal Endoscopic Management of Localized Atticoantral Cholesteatoma Patients
NA · Sohag University · NCT06246682
This study is testing how the health of the mastoid bone and different ways to rebuild hearing bones affect the success of endoscopic surgery for people with a specific type of ear condition called cholesteatoma.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 25 (estimated) |
| Ages | 12 Years and up |
| Sex | All |
| Sponsor | Sohag University (other) |
| Locations | 1 site (Sohag) |
| Trial ID | NCT06246682 on ClinicalTrials.gov |
What this trial studies
This interventional study aims to investigate how the condition of the mastoid process and the method of ossicular reconstruction influence the outcomes of transcanal endoscopic management in patients with localized atticoantral cholesteatoma. It focuses on patients with primary acquired cholesteatoma, assessing the effectiveness of endoscopic removal techniques. The study will evaluate various factors, including the presence of symptoms and the extent of the cholesteatoma, to determine optimal management strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 12 years and older with primary acquired localized atticoantral cholesteatoma.
Not a fit: Patients with congenital or secondary acquired cholesteatoma, extensive, residual, or recurrent cholesteatoma, or craniofacial anomalies may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve surgical outcomes and hearing restoration for patients with cholesteatoma.
How similar studies have performed: While there have been studies on cholesteatoma management, this specific approach focusing on mastoid condition and endoscopic techniques is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients presenting with primary acquired localized atticoantral cholesteatoma. Exclusion Criteria: * Age group: patients below 12 years old. * Patients presenting with congenital or secondary acquired cholesteatoma. * Patients presenting with extensive, residual, or recurrent cholesteatoma. * Patients with craniofacial anomalies.
Where this trial is running
Sohag
- faculty of medicine Sohag university — Sohag, Egypt (RECRUITING)
Study contacts
- Principal investigator: farghali Abdelrahman — Sohag University
- Study coordinator: farghali abdelrahman, master
- Email: farghali_abdelaziz@med.sohag.edu.eg
- Phone: 01067063919
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cholesteatoma of Attic, Cholesteatoma, Middle Ear, cholesteatoma, Endoscopic ear surgery, mastoid process